
    
      Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

      This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled
      patients will be 11 patients with active takayasu's arteritis
    
  